Cargando…
Treatment of opioid withdrawal in neonates with morphine, phenobarbital, or chlorpromazine: a randomized double-blind trial
Three suitable compounds (morphine, chlorpromazine, and phenobarbital) to treat neonatal abstinence syndrome were compared in a prospective multicenter, double-blind trial. Neonates exposed to opioids in utero were randomly allocated to one of three treatment groups. When a predefined threshold of a...
Autores principales: | Zimmermann, Urs, Rudin, Christoph, Duò, Angelo, Held, Leonhard, Bucher, Hans Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942588/ https://www.ncbi.nlm.nih.gov/pubmed/31691849 http://dx.doi.org/10.1007/s00431-019-03486-6 |
Ejemplares similares
-
A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal
por: Chisamore, Brian, et al.
Publicado: (2016) -
Dose‐dependent naloxone‐induced morphine withdrawal symptoms in opioid‐dependent males—a double‐blinded, randomized study
por: Weisshaar, Stefan, et al.
Publicado: (2020) -
Phenobarbital versus morphine in the management of neonatal abstinence syndrome, a randomized control trial
por: Nayeri, Fatemeh, et al.
Publicado: (2015) -
Phenobarbital for Alcohol Withdrawal: Rapid Patient Disposition
por: Richards, John R.
Publicado: (2000) -
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
por: Sutter, Mary Beth, et al.
Publicado: (2022)